51 related articles for article (PubMed ID: 11697825)
1. Bone health in cancer: ESMO Clinical Practice Guidelines.
Coleman R; Hadji P; Body JJ; Santini D; Chow E; Terpos E; Oudard S; Bruland Ø; Flamen P; Kurth A; Van Poznak C; Aapro M; Jordan K;
Ann Oncol; 2020 Dec; 31(12):1650-1663. PubMed ID: 32801018
[No Abstract] [Full Text] [Related]
2. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
González-Martín A; Harter P; Leary A; Lorusso D; Miller RE; Pothuri B; Ray-Coquard I; Tan DSP; Bellet E; Oaknin A; Ledermann JA;
Ann Oncol; 2023 Oct; 34(10):833-848. PubMed ID: 37597580
[No Abstract] [Full Text] [Related]
3. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
[TBL] [Abstract][Full Text] [Related]
4. Proteomics Analysis of Ovarian Cancer Cell Lines and Tissues Reveals Drug Resistance-associated Proteins.
Cruz IN; Coley HM; Kramer HB; Madhuri TK; Safuwan NA; Angelino AR; Yang M
Cancer Genomics Proteomics; 2017 Jan; 14(1):35-51. PubMed ID: 28031236
[TBL] [Abstract][Full Text] [Related]
5. S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.
Wagner U; Harter P; Hilpert F; Mahner S; Reuß A; du Bois A; Petru E; Meier W; Ortner P; König K; Lindel K; Grab D; Piso P; Ortmann O; Runnebaum I; Pfisterer J; Lüftner D; Frickhofen N; Grünwald F; Maier BO; Diebold J; Hauptmann S; Kommoss F; Emons G; Radeleff B; Gebhardt M; Arnold N; Calaminus G; Weisse I; Weis J; Sehouli J; Fink D; Burges A; Hasenburg A; Eggert C
Geburtshilfe Frauenheilkd; 2013 Sep; 73(9):874-889. PubMed ID: 24771937
[No Abstract] [Full Text] [Related]
6. Primary ovarian rhabdomyosarcoma: a report of 13 cases.
Nielsen GP; Oliva E; Young RH; Rosenberg AE; Prat J; Scully RE
Int J Gynecol Pathol; 1998 Apr; 17(2):113-9. PubMed ID: 9553806
[TBL] [Abstract][Full Text] [Related]
7. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Colombo N; Peiretti M; Garbi A; Carinelli S; Marini C; Sessa C;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii20-6. PubMed ID: 22997450
[No Abstract] [Full Text] [Related]
8. [Chemotherapy and prognostic significance of the size of the remaining tumor in ovarian cancer].
Petru E; Lahousen M; Pickel H; Stettner H
Gynakol Rundsch; 1989; 29 Suppl 2():413-4. PubMed ID: 2613067
[No Abstract] [Full Text] [Related]
9. Ovarian cancer.
Bapsy PP
J Indian Med Assoc; 2012 Dec; 110(12):894-7. PubMed ID: 23936953
[No Abstract] [Full Text] [Related]
10. [Therapy of advanced ovarian carcinoma].
Pfisterer J
Krankenpfl J; 2004; 42(1-2):18-9. PubMed ID: 15116769
[No Abstract] [Full Text] [Related]
11. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma.
Ann Oncol; 2001 Sep; 12(9):1209-10. PubMed ID: 11697826
[No Abstract] [Full Text] [Related]
12. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of ovarian cancer.
Ann Oncol; 2001 Sep; 12(9):1205-7. PubMed ID: 11697825
[No Abstract] [Full Text] [Related]
13. [Ovarian carcinoma in the elderly; a diagnostic and therapeutic dilemma].
Wymenga AN; Willemse PH; Aalders JG; Sleijfer DT
Ned Tijdschr Geneeskd; 1996 Mar; 140(12):650-3. PubMed ID: 8668237
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
